99616-5 |
Trienoate/Arachidonate |
SRto |
RBC.lysate |
Pt |
Qn |
|
|
ACTIVE |
Trienoate (C20:3w9)/Arachidonate (C20:4w6) [Molar ratio] in RBC.lysate |
|
ADD |
DefinitionDescription |
|
|
{ratio} |
|
|
|
|
|
|
CHEM |
|
99616-5 |
|
|
|
|
Observation |
|
|
|
0 |
Trienoate/AA RBC.lysate-sRto |
|
|
|
N |
|
5,8,11,14 Eicosatetraenoic acid; 5,8,11-eicosatrienoic acid 20:3 w9; AA; Arachidonic acid; Arch acid; C20:4w6; Chemistry; Eicosatetraenoate; Erythrocytes; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; Scrto; Substance concentration ratio; Substance ratio; Trienoic acid |
2.72 |
2.72 |
|
|
|
|
|
|
|
{ratio} |
|
|
|
0 |
99617-3 |
Fatty acids.saturated |
SCnc |
RBC.lysate |
Pt |
Qn |
|
|
ACTIVE |
Saturated fatty acids [Moles/volume] in RBC.lysate |
|
ADD |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHEM |
|
99617-3 |
|
|
|
|
Observation |
|
|
|
0 |
Sat FA RBC.lysate-sCnc |
|
|
|
N |
|
Acd; Acid; Chemistry; Erythrocytes; Fatty acid; Level; Lipid; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; Sat FA; Substance Concentration |
2.72 |
2.72 |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
99618-1 |
Fatty acids.monounsaturated |
SCnc |
RBC.lysate |
Pt |
Qn |
|
|
ACTIVE |
Monounsaturated fatty acids [Moles/volume] in RBC.lysate |
|
ADD |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHEM |
|
99618-1 |
|
|
|
|
Observation |
|
|
|
0 |
Monounsat FA RBC.lysate-sCnc |
|
|
|
N |
|
Acd; Acid; Chemistry; Erythrocytes; Fatty acid; Level; Lipid; Monounsat FA; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; Substance concentration |
2.72 |
2.72 |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
99619-9 |
Fatty acids.polyunsaturated |
SCnc |
RBC.lysate |
Pt |
Qn |
|
|
ACTIVE |
Polyunsaturated fatty acids [Moles/volume] in RBC.lysate |
|
ADD |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHEM |
|
99619-9 |
|
|
|
|
Observation |
|
|
|
0 |
Polyunsat FA RBC.lysate-sCnc |
|
|
|
N |
|
Acd; Acid; Chemistry; Erythrocytes; Fatty acid; Level; Lipid; Point in time; Polyunsat FA; PUFA; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; Substance concentration |
2.72 |
2.72 |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
9962-2 |
QRS initial amplitude.lead AVL |
Elpot |
Heart |
Pt |
Qn |
EKG |
|
ACTIVE |
QRS initial amplitude in lead AVL |
|
MIN |
DefinitionDescription |
|
|
mV |
|
|
|
|
|
|
EKG.MEAS |
|
9962-2 |
|
EKG |
|
|
Observation |
|
|
|
0 |
QRS I-Amp L-AVL |
|
|
|
Y |
|
Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; QRS I-Amp L-AVL; Quan; Quant; Quantitative; Random; Voltage |
2.48 |
1.0i |
|
|
|
|
|
|
|
mV |
|
|
|
0 |
99620-7 |
Fatty acids.omega 3 |
SCnc |
RBC.lysate |
Pt |
Qn |
|
|
ACTIVE |
Omega 3 fatty acids (w3) [Moles/volume] in RBC.lysate |
|
ADD |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHEM |
|
99620-7 |
|
|
|
|
Observation |
|
|
|
0 |
w3 FA RBC.lysate-sCnc |
|
|
|
N |
|
Acd; Acid; Chemistry; Erythrocytes; Fatty acid; III; Level; Lipid; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; Substance concentration; w3 FA |
2.72 |
2.72 |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
99621-5 |
Fatty acids.omega 6 |
SCnc |
RBC.lysate |
Pt |
Qn |
|
|
ACTIVE |
Omega 6 fatty acids (w6) [Moles/volume] in RBC.lysate |
|
ADD |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHEM |
|
99621-5 |
|
|
|
|
Observation |
|
|
|
0 |
w6 FA RBC.lysate-sCnc |
|
|
|
N |
|
Acd; Acid; Chemistry; Erythrocytes; Fatty acid; Level; Lipid; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; Substance concentration; w6 FA |
2.72 |
2.72 |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
99622-3 |
Resource information for patient |
Find |
^Patient |
Pt |
Doc |
|
|
ACTIVE |
Resource information for patient |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.MISC |
|
99622-3 |
|
|
|
|
Observation |
|
|
|
0 |
Patient resource info |
|
|
|
N |
|
DOC.MISC; Document; Finding; Findings; MISC; Patient resource info; Point in time; Random |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99623-1 |
Influenza virus A N1 RNA |
PrThr |
XXX |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Influenza virus A N1 RNA [Presence] in Specimen by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
99623-1 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
FLUAV N1 RNA Spec Ql NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian influenza; Bird flu; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUAV; FLUAV N1; FLUV; Fowl plague; Influ; Influenza A; Influenza A virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99624-9 |
Japanese encephalitis virus Ab.IgG |
PrThr |
Ser |
Pt |
Ord |
IA |
|
ACTIVE |
Japanese encephalitis virus IgG Ab [Presence] in Serum by Immunoassay |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
99624-9 |
|
IA |
|
|
Both |
|
|
|
0 |
JEV IgG Ser Ql IA |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enc; Enceph; Encephalomyelitis; Enzyme immunoassay; Flavivirus; IAA; Immune globulin G; Immunoglobulin G; Japanese B encephalitis; Japanese encephalitis; JBE; JE virus; JEV; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99625-6 |
Purkinje cell cytoplasmic type 2 Ab |
PrThr |
Ser |
Pt |
Ord |
Line blot |
|
ACTIVE |
PCA-2 Ab [Presence] in Serum by Line blot |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
99625-6 |
|
Line blot |
|
|
Both |
|
|
|
0 |
PCA-2 Ab Ser Ql Line blot |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cytopl; Cytoplas; II; Ordinal; Paraneoplastic syndrome; PCA-2; PCA-2 Ab; PCCA-2; Point in time; PR; Purkinje cell cytoplasmic antibody; Purkinje cells; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99626-4 |
Purkinje cell cytoplasmic type 2 Ab |
PrThr |
CSF |
Pt |
Ord |
Line blot |
|
ACTIVE |
PCA-2 Ab [Presence] in Cerebral spinal fluid by Line blot |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
99626-4 |
|
Line blot |
|
|
Both |
|
|
|
0 |
PCA-2 Ab CSF Ql Line blot |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Cytopl; Cytoplas; II; Ordinal; Paraneoplastic syndrome; PCA-2; PCA-2 Ab; PCCA-2; Point in time; PR; Purkinje cell cytoplasmic antibody; Purkinje cells; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99627-2 |
How often does this describe you, I don't have enough money to pay my bills |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
How often does this describe you, I don't have enough money to pay my bills |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.SDOH |
|
99627-2 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; T prime |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99628-0 |
Multisection |
Find |
Neck+Chest+Abdomen+Pelvis |
Pt |
Doc |
CT |
|
ACTIVE |
CT Neck+Chest+Abdomen+Pelvis |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
RAD |
|
99628-0 |
|
CT |
|
|
Both |
|
|
|
0 |
CT Neck to Pelvis |
|
|
|
N |
|
Abd; Abd+Pelvis; Abdo; Abdominal; CAT scan; Chest + Abd; Chest+Abd+Pelvis; Computed tomography; Computerized tomography; CT scan; Document; Finding; Findings; Imaging; Neck to Pelvis; Pelvic; Point in time; Radiology; Random; Thorax |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99629-8 |
Multisection^WO contrast |
Find |
Neck+Chest+Abdomen+Pelvis |
Pt |
Doc |
CT |
|
ACTIVE |
CT Neck+Chest+Abdomen+Pelvis WO contrast |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
RAD |
|
99629-8 |
|
CT |
|
|
Both |
|
|
|
0 |
CT Neck to Pelvis WO contr |
|
|
|
N |
|
Abd; Abd+Pelvis; Abdo; Abdominal; c; CAT scan; Chest + Abd; Chest+Abd+Pelvis; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Finding; Findings; Imaging; Neck to Pelvis; Pelvic; Point in time; Radiology; Random; Thorax; without contrast |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
9963-0 |
QRS initial amplitude.lead AVR |
Elpot |
Heart |
Pt |
Qn |
EKG |
|
ACTIVE |
QRS initial amplitude in lead AVR |
|
MIN |
DefinitionDescription |
|
|
mV |
|
|
|
|
|
|
EKG.MEAS |
|
9963-0 |
|
EKG |
|
|
Observation |
|
|
|
0 |
QRS I-Amp L-AVR |
|
|
|
Y |
|
Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; QRS I-Amp L-AVR; Quan; Quant; Quantitative; Random; Voltage |
2.48 |
1.0i |
|
|
|
|
|
|
|
mV |
|
|
|
0 |
99630-6 |
Multisection^WO & W contrast IV |
Find |
Neck+Chest+Abdomen+Pelvis |
Pt |
Doc |
CT |
|
ACTIVE |
CT Neck+Chest+Abdomen+Pelvis WO and W contrast IV |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
RAD |
|
99630-6 |
|
CT |
|
|
Both |
|
|
|
0 |
CT Neck to Pelvis WO+W contr IV |
|
|
|
N |
|
Abd; Abd+Pelvis; Abdo; Abdominal; c; CAT scan; Chest + Abd; Chest+Abd+Pelvis; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Finding; Findings; Imaging; Neck to Pelvis; Pelvic; Point in time; Radiology; Random; Thorax; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99631-4 |
Multisection |
Find |
Head>Temporomandibular joint.bilateral |
Pt |
Doc |
CT.cone beam |
|
ACTIVE |
Cone beam CT Temporomandibular joint - bilateral |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
RAD |
|
99631-4 |
|
CT.cone beam |
|
|
Both |
|
|
|
0 |
CBCT TMJ-Bl |
|
|
|
N |
|
Bil; Bilat; Both; Brain; CAT scan; CBCT; Computed tomography; Computerized tomography; Cone beam CT; Cranial; Cranium; CT scan; Document; Finding; Findings; Imaging; Intracranial; Jnt; Point in time; Radiology; Random; Skull; TMJ; TMJ-Bl; TMJS |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99632-2 |
Multisection^WO & W contrast IV |
Find |
Head>Temporomandibular joint |
Pt |
Doc |
CT.cone beam |
|
ACTIVE |
Cone beam CT Temporomandibular joint WO and W contrast IV |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
RAD |
|
99632-2 |
|
CT.cone beam |
|
|
Both |
|
|
|
0 |
CBCT TMJ WO+W contr IV |
|
|
|
N |
|
Brain; c; CAT scan; CBCT; Computed tomography; Computerized tomography; Cone beam CT; Contr; Contra; Contrst; Cranial; Cranium; CT scan; Document; Finding; Findings; Imaging; Intracranial; Jnt; Point in time; Radiology; Random; Skull; TMJ; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99633-0 |
Multisection |
Find |
Head>Teeth |
Pt |
Doc |
CT.cone beam |
|
ACTIVE |
Cone beam CT Teeth |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
RAD |
|
99633-0 |
|
CT.cone beam |
|
|
Both |
|
|
|
0 |
CBCT Teeth |
|
|
|
N |
|
Brain; CAT scan; CBCT; Computed tomography; Computerized tomography; Cone beam CT; Cranial; Cranium; CT scan; Dental scan; Dentascan; Document; Finding; Findings; Imaging; Intracranial; Point in time; Radiology; Random; Skull |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99634-8 |
Federal, state, or local governments required limiting non-essential travel |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Federal, state, or local governments required limiting non-essential travel |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.COVID |
|
99634-8 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99635-5 |
Main symptoms experienced by people infected with condition of interest |
Find |
^Patient |
Pt |
Nom |
|
|
ACTIVE |
Main symptoms experienced by people infected with condition of interest |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.GNHLTH |
|
99635-5 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Disease; Disorder; Finding; Findings; Nominal; Point in time; Random; Survey; SURVEY.GNHLTH; Sx; Virus |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99636-3 |
Activity related to possible exposure to condition of interest |
Find |
^Patient |
7D |
Nom |
|
|
ACTIVE |
Activity related to possible exposure to condition of interest |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.GNHLTH |
|
99636-3 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Activ; Actvty; Disease; Disorder; Exp; Finding; Findings; Movements; Nominal; Survey; SURVEY.GNHLTH; Virus |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99637-1 |
Measures taken to keep safe from condition of interest |
Find |
^Patient |
RptPeriod |
Nom |
|
|
ACTIVE |
Measures taken to keep safe from condition of interest |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.GNHLTH |
|
99637-1 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Disease; Disorder; Finding; Findings; Nominal; Report period; Survey; SURVEY.GNHLTH; Virus |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99638-9 |
Federal, state, or local governments encouraged limiting non-essential travel |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Federal, state, or local governments encouraged limiting non-essential travel |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.COVID |
|
99638-9 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |